Source Name Characteristics[organism] Characteristics[taxonomy_id] Characteristics[age] Characteristics[biomaterial_provider] Characteristics[isolate] Characteristics[sex] Characteristics[tissue] Characteristics[disease] Characteristics[complications] Comment[BioSample] Comment[sample_title] Comment[description] Protocol REF Sample Name Protocol REF Parameter Value[Post extraction] Parameter Value[Derivatization] Extract Name Protocol REF Parameter Value[Chromatography instrument] Parameter Value[Autosampler model] Parameter Value[Column model] Parameter Value[Column type] Parameter Value[Guard column] Labeled Extract Name Label Protocol REF Parameter Value[Scan polarity] Parameter Value[Scan m/z range] Parameter Value[Instrument] Parameter Value[Ion source] Parameter Value[Mass analyzer] Assay Name Comment[technical_replicate] Raw Data File Protocol REF Processed Data File Processed Data File Protocol REF Metabolite Assignment File Comment[maf_value_unit] Factor Value[complications] T2D_1 Homo sapiens 9606 restricted access BioBankJapan T2D_1 male serum type 2 diabetes controlled access SAMD00552597 serum sample from blood of T2D subject T2D_1 serum from person with type 2 diabetes Sample collection T2D_1 Extraction T2D_1 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_1 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_2 Homo sapiens 9606 restricted access BioBankJapan T2D_2 female serum type 2 diabetes controlled access SAMD00552598 serum sample from blood of T2D subject T2D_2 serum from person with type 2 diabetes Sample collection T2D_2 Extraction T2D_2 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_2 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_3 Homo sapiens 9606 restricted access BioBankJapan T2D_3 female serum type 2 diabetes controlled access SAMD00552599 serum sample from blood of T2D subject T2D_3 serum from person with type 2 diabetes Sample collection T2D_3 Extraction T2D_3 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_3 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_4 Homo sapiens 9606 restricted access BioBankJapan T2D_4 female serum type 2 diabetes controlled access SAMD00552600 serum sample from blood of T2D subject T2D_4 serum from person with type 2 diabetes Sample collection T2D_4 Extraction T2D_4 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_4 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_5 Homo sapiens 9606 restricted access BioBankJapan T2D_5 male serum type 2 diabetes controlled access SAMD00552601 serum sample from blood of T2D subject T2D_5 serum from person with type 2 diabetes Sample collection T2D_5 Extraction T2D_5 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_5 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_6 Homo sapiens 9606 restricted access BioBankJapan T2D_6 male serum type 2 diabetes controlled access SAMD00552602 serum sample from blood of T2D subject T2D_6 serum from person with type 2 diabetes Sample collection T2D_6 Extraction T2D_6 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_6 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_7 Homo sapiens 9606 restricted access BioBankJapan T2D_7 male serum type 2 diabetes controlled access SAMD00552603 serum sample from blood of T2D subject T2D_7 serum from person with type 2 diabetes Sample collection T2D_7 Extraction T2D_7 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_7 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_8 Homo sapiens 9606 restricted access BioBankJapan T2D_8 male serum type 2 diabetes controlled access SAMD00552604 serum sample from blood of T2D subject T2D_8 serum from person with type 2 diabetes Sample collection T2D_8 Extraction T2D_8 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_8 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_9 Homo sapiens 9606 restricted access BioBankJapan T2D_9 male serum type 2 diabetes controlled access SAMD00552605 serum sample from blood of T2D subject T2D_9 serum from person with type 2 diabetes Sample collection T2D_9 Extraction T2D_9 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_9 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_10 Homo sapiens 9606 restricted access BioBankJapan T2D_10 male serum type 2 diabetes controlled access SAMD00552606 serum sample from blood of T2D subject T2D_10 serum from person with type 2 diabetes Sample collection T2D_10 Extraction T2D_10 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_10 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_11 Homo sapiens 9606 restricted access BioBankJapan T2D_11 male serum type 2 diabetes controlled access SAMD00552607 serum sample from blood of T2D subject T2D_11 serum from person with type 2 diabetes Sample collection T2D_11 Extraction T2D_11 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_11 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_12 Homo sapiens 9606 restricted access BioBankJapan T2D_12 female serum type 2 diabetes controlled access SAMD00552608 serum sample from blood of T2D subject T2D_12 serum from person with type 2 diabetes Sample collection T2D_12 Extraction T2D_12 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_12 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_13 Homo sapiens 9606 restricted access BioBankJapan T2D_13 male serum type 2 diabetes controlled access SAMD00552609 serum sample from blood of T2D subject T2D_13 serum from person with type 2 diabetes Sample collection T2D_13 Extraction T2D_13 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_13 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_14 Homo sapiens 9606 restricted access BioBankJapan T2D_14 female serum type 2 diabetes controlled access SAMD00552610 serum sample from blood of T2D subject T2D_14 serum from person with type 2 diabetes Sample collection T2D_14 Extraction T2D_14 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_14 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_15 Homo sapiens 9606 restricted access BioBankJapan T2D_15 male serum type 2 diabetes controlled access SAMD00552611 serum sample from blood of T2D subject T2D_15 serum from person with type 2 diabetes Sample collection T2D_15 Extraction T2D_15 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_15 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_16 Homo sapiens 9606 restricted access BioBankJapan T2D_16 male serum type 2 diabetes controlled access SAMD00552612 serum sample from blood of T2D subject T2D_16 serum from person with type 2 diabetes Sample collection T2D_16 Extraction T2D_16 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_16 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_17 Homo sapiens 9606 restricted access BioBankJapan T2D_17 female serum type 2 diabetes controlled access SAMD00552613 serum sample from blood of T2D subject T2D_17 serum from person with type 2 diabetes Sample collection T2D_17 Extraction T2D_17 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_17 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_18 Homo sapiens 9606 restricted access BioBankJapan T2D_18 female serum type 2 diabetes controlled access SAMD00552614 serum sample from blood of T2D subject T2D_18 serum from person with type 2 diabetes Sample collection T2D_18 Extraction T2D_18 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_18 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_19 Homo sapiens 9606 restricted access BioBankJapan T2D_19 female serum type 2 diabetes controlled access SAMD00552615 serum sample from blood of T2D subject T2D_19 serum from person with type 2 diabetes Sample collection T2D_19 Extraction T2D_19 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_19 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_20 Homo sapiens 9606 restricted access BioBankJapan T2D_20 male serum type 2 diabetes controlled access SAMD00552616 serum sample from blood of T2D subject T2D_20 serum from person with type 2 diabetes Sample collection T2D_20 Extraction T2D_20 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_20 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_21 Homo sapiens 9606 restricted access BioBankJapan T2D_21 male serum type 2 diabetes controlled access SAMD00552617 serum sample from blood of T2D subject T2D_21 serum from person with type 2 diabetes Sample collection T2D_21 Extraction T2D_21 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_21 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_22 Homo sapiens 9606 restricted access BioBankJapan T2D_22 male serum type 2 diabetes controlled access SAMD00552618 serum sample from blood of T2D subject T2D_22 serum from person with type 2 diabetes Sample collection T2D_22 Extraction T2D_22 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_22 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_23 Homo sapiens 9606 restricted access BioBankJapan T2D_23 female serum type 2 diabetes controlled access SAMD00552619 serum sample from blood of T2D subject T2D_23 serum from person with type 2 diabetes Sample collection T2D_23 Extraction T2D_23 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_23 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_24 Homo sapiens 9606 restricted access BioBankJapan T2D_24 female serum type 2 diabetes controlled access SAMD00552620 serum sample from blood of T2D subject T2D_24 serum from person with type 2 diabetes Sample collection T2D_24 Extraction T2D_24 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_24 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_25 Homo sapiens 9606 restricted access BioBankJapan T2D_25 male serum type 2 diabetes controlled access SAMD00552621 serum sample from blood of T2D subject T2D_25 serum from person with type 2 diabetes Sample collection T2D_25 Extraction T2D_25 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_25 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_26 Homo sapiens 9606 restricted access BioBankJapan T2D_26 female serum type 2 diabetes controlled access SAMD00552622 serum sample from blood of T2D subject T2D_26 serum from person with type 2 diabetes Sample collection T2D_26 Extraction T2D_26 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_26 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_27 Homo sapiens 9606 restricted access BioBankJapan T2D_27 female serum type 2 diabetes controlled access SAMD00552623 serum sample from blood of T2D subject T2D_27 serum from person with type 2 diabetes Sample collection T2D_27 Extraction T2D_27 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_27 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_28 Homo sapiens 9606 restricted access BioBankJapan T2D_28 male serum type 2 diabetes controlled access SAMD00552624 serum sample from blood of T2D subject T2D_28 serum from person with type 2 diabetes Sample collection T2D_28 Extraction T2D_28 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_28 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_29 Homo sapiens 9606 restricted access BioBankJapan T2D_29 male serum type 2 diabetes controlled access SAMD00552625 serum sample from blood of T2D subject T2D_29 serum from person with type 2 diabetes Sample collection T2D_29 Extraction T2D_29 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_29 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_30 Homo sapiens 9606 restricted access BioBankJapan T2D_30 female serum type 2 diabetes controlled access SAMD00552626 serum sample from blood of T2D subject T2D_30 serum from person with type 2 diabetes Sample collection T2D_30 Extraction T2D_30 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_30 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_31 Homo sapiens 9606 restricted access BioBankJapan T2D_31 female serum type 2 diabetes controlled access SAMD00552627 serum sample from blood of T2D subject T2D_31 serum from person with type 2 diabetes Sample collection T2D_31 Extraction T2D_31 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_31 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_32 Homo sapiens 9606 restricted access BioBankJapan T2D_32 male serum type 2 diabetes controlled access SAMD00552628 serum sample from blood of T2D subject T2D_32 serum from person with type 2 diabetes Sample collection T2D_32 Extraction T2D_32 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_32 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_33 Homo sapiens 9606 restricted access BioBankJapan T2D_33 female serum type 2 diabetes controlled access SAMD00552629 serum sample from blood of T2D subject T2D_33 serum from person with type 2 diabetes Sample collection T2D_33 Extraction T2D_33 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_33 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_34 Homo sapiens 9606 restricted access BioBankJapan T2D_34 male serum type 2 diabetes controlled access SAMD00552630 serum sample from blood of T2D subject T2D_34 serum from person with type 2 diabetes Sample collection T2D_34 Extraction T2D_34 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_34 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_35 Homo sapiens 9606 restricted access BioBankJapan T2D_35 male serum type 2 diabetes controlled access SAMD00552631 serum sample from blood of T2D subject T2D_35 serum from person with type 2 diabetes Sample collection T2D_35 Extraction T2D_35 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_35 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_36 Homo sapiens 9606 restricted access BioBankJapan T2D_36 female serum type 2 diabetes controlled access SAMD00552632 serum sample from blood of T2D subject T2D_36 serum from person with type 2 diabetes Sample collection T2D_36 Extraction T2D_36 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_36 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_37 Homo sapiens 9606 restricted access BioBankJapan T2D_37 male serum type 2 diabetes controlled access SAMD00552633 serum sample from blood of T2D subject T2D_37 serum from person with type 2 diabetes Sample collection T2D_37 Extraction T2D_37 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_37 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_38 Homo sapiens 9606 restricted access BioBankJapan T2D_38 male serum type 2 diabetes controlled access SAMD00552634 serum sample from blood of T2D subject T2D_38 serum from person with type 2 diabetes Sample collection T2D_38 Extraction T2D_38 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_38 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_39 Homo sapiens 9606 restricted access BioBankJapan T2D_39 female serum type 2 diabetes controlled access SAMD00552635 serum sample from blood of T2D subject T2D_39 serum from person with type 2 diabetes Sample collection T2D_39 Extraction T2D_39 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_39 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_40 Homo sapiens 9606 restricted access BioBankJapan T2D_40 male serum type 2 diabetes controlled access SAMD00552636 serum sample from blood of T2D subject T2D_40 serum from person with type 2 diabetes Sample collection T2D_40 Extraction T2D_40 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_40 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_41 Homo sapiens 9606 restricted access BioBankJapan T2D_41 male serum type 2 diabetes controlled access SAMD00552637 serum sample from blood of T2D subject T2D_41 serum from person with type 2 diabetes Sample collection T2D_41 Extraction T2D_41 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_41 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_42 Homo sapiens 9606 restricted access BioBankJapan T2D_42 male serum type 2 diabetes controlled access SAMD00552638 serum sample from blood of T2D subject T2D_42 serum from person with type 2 diabetes Sample collection T2D_42 Extraction T2D_42 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_42 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_43 Homo sapiens 9606 restricted access BioBankJapan T2D_43 male serum type 2 diabetes controlled access SAMD00552639 serum sample from blood of T2D subject T2D_43 serum from person with type 2 diabetes Sample collection T2D_43 Extraction T2D_43 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_43 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_44 Homo sapiens 9606 restricted access BioBankJapan T2D_44 male serum type 2 diabetes controlled access SAMD00552640 serum sample from blood of T2D subject T2D_44 serum from person with type 2 diabetes Sample collection T2D_44 Extraction T2D_44 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_44 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_45 Homo sapiens 9606 restricted access BioBankJapan T2D_45 male serum type 2 diabetes controlled access SAMD00552641 serum sample from blood of T2D subject T2D_45 serum from person with type 2 diabetes Sample collection T2D_45 Extraction T2D_45 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_45 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_46 Homo sapiens 9606 restricted access BioBankJapan T2D_46 female serum type 2 diabetes controlled access SAMD00552642 serum sample from blood of T2D subject T2D_46 serum from person with type 2 diabetes Sample collection T2D_46 Extraction T2D_46 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_46 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_47 Homo sapiens 9606 restricted access BioBankJapan T2D_47 male serum type 2 diabetes controlled access SAMD00552643 serum sample from blood of T2D subject T2D_47 serum from person with type 2 diabetes Sample collection T2D_47 Extraction T2D_47 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_47 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_48 Homo sapiens 9606 restricted access BioBankJapan T2D_48 male serum type 2 diabetes controlled access SAMD00552644 serum sample from blood of T2D subject T2D_48 serum from person with type 2 diabetes Sample collection T2D_48 Extraction T2D_48 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_48 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_49 Homo sapiens 9606 restricted access BioBankJapan T2D_49 male serum type 2 diabetes controlled access SAMD00552645 serum sample from blood of T2D subject T2D_49 serum from person with type 2 diabetes Sample collection T2D_49 Extraction T2D_49 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_49 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_50 Homo sapiens 9606 restricted access BioBankJapan T2D_50 male serum type 2 diabetes controlled access SAMD00552646 serum sample from blood of T2D subject T2D_50 serum from person with type 2 diabetes Sample collection T2D_50 Extraction T2D_50 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_50 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_51 Homo sapiens 9606 restricted access BioBankJapan T2D_51 female serum type 2 diabetes controlled access SAMD00552647 serum sample from blood of T2D subject T2D_51 serum from person with type 2 diabetes Sample collection T2D_51 Extraction T2D_51 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_51 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_52 Homo sapiens 9606 restricted access BioBankJapan T2D_52 female serum type 2 diabetes controlled access SAMD00552648 serum sample from blood of T2D subject T2D_52 serum from person with type 2 diabetes Sample collection T2D_52 Extraction T2D_52 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_52 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_53 Homo sapiens 9606 restricted access BioBankJapan T2D_53 male serum type 2 diabetes controlled access SAMD00552649 serum sample from blood of T2D subject T2D_53 serum from person with type 2 diabetes Sample collection T2D_53 Extraction T2D_53 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_53 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_54 Homo sapiens 9606 restricted access BioBankJapan T2D_54 male serum type 2 diabetes controlled access SAMD00552650 serum sample from blood of T2D subject T2D_54 serum from person with type 2 diabetes Sample collection T2D_54 Extraction T2D_54 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_54 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_55 Homo sapiens 9606 restricted access BioBankJapan T2D_55 male serum type 2 diabetes controlled access SAMD00552651 serum sample from blood of T2D subject T2D_55 serum from person with type 2 diabetes Sample collection T2D_55 Extraction T2D_55 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_55 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_56 Homo sapiens 9606 restricted access BioBankJapan T2D_56 male serum type 2 diabetes controlled access SAMD00552652 serum sample from blood of T2D subject T2D_56 serum from person with type 2 diabetes Sample collection T2D_56 Extraction T2D_56 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_56 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_57 Homo sapiens 9606 restricted access BioBankJapan T2D_57 female serum type 2 diabetes controlled access SAMD00552653 serum sample from blood of T2D subject T2D_57 serum from person with type 2 diabetes Sample collection T2D_57 Extraction T2D_57 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_57 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_58 Homo sapiens 9606 restricted access BioBankJapan T2D_58 female serum type 2 diabetes controlled access SAMD00552654 serum sample from blood of T2D subject T2D_58 serum from person with type 2 diabetes Sample collection T2D_58 Extraction T2D_58 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_58 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_59 Homo sapiens 9606 restricted access BioBankJapan T2D_59 male serum type 2 diabetes controlled access SAMD00552655 serum sample from blood of T2D subject T2D_59 serum from person with type 2 diabetes Sample collection T2D_59 Extraction T2D_59 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_59 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_60 Homo sapiens 9606 restricted access BioBankJapan T2D_60 male serum type 2 diabetes controlled access SAMD00552656 serum sample from blood of T2D subject T2D_60 serum from person with type 2 diabetes Sample collection T2D_60 Extraction T2D_60 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_60 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_61 Homo sapiens 9606 restricted access BioBankJapan T2D_61 male serum type 2 diabetes controlled access SAMD00552657 serum sample from blood of T2D subject T2D_61 serum from person with type 2 diabetes Sample collection T2D_61 Extraction T2D_61 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_61 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_62 Homo sapiens 9606 restricted access BioBankJapan T2D_62 female serum type 2 diabetes controlled access SAMD00552658 serum sample from blood of T2D subject T2D_62 serum from person with type 2 diabetes Sample collection T2D_62 Extraction T2D_62 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_62 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_63 Homo sapiens 9606 restricted access BioBankJapan T2D_63 female serum type 2 diabetes controlled access SAMD00552659 serum sample from blood of T2D subject T2D_63 serum from person with type 2 diabetes Sample collection T2D_63 Extraction T2D_63 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_63 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_64 Homo sapiens 9606 restricted access BioBankJapan T2D_64 female serum type 2 diabetes controlled access SAMD00552660 serum sample from blood of T2D subject T2D_64 serum from person with type 2 diabetes Sample collection T2D_64 Extraction T2D_64 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_64 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_65 Homo sapiens 9606 restricted access BioBankJapan T2D_65 male serum type 2 diabetes controlled access SAMD00552661 serum sample from blood of T2D subject T2D_65 serum from person with type 2 diabetes Sample collection T2D_65 Extraction T2D_65 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_65 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_66 Homo sapiens 9606 restricted access BioBankJapan T2D_66 male serum type 2 diabetes controlled access SAMD00552662 serum sample from blood of T2D subject T2D_66 serum from person with type 2 diabetes Sample collection T2D_66 Extraction T2D_66 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_66 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_67 Homo sapiens 9606 restricted access BioBankJapan T2D_67 male serum type 2 diabetes controlled access SAMD00552663 serum sample from blood of T2D subject T2D_67 serum from person with type 2 diabetes Sample collection T2D_67 Extraction T2D_67 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_67 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_68 Homo sapiens 9606 restricted access BioBankJapan T2D_68 male serum type 2 diabetes controlled access SAMD00552664 serum sample from blood of T2D subject T2D_68 serum from person with type 2 diabetes Sample collection T2D_68 Extraction T2D_68 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_68 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_69 Homo sapiens 9606 restricted access BioBankJapan T2D_69 female serum type 2 diabetes controlled access SAMD00552665 serum sample from blood of T2D subject T2D_69 serum from person with type 2 diabetes Sample collection T2D_69 Extraction T2D_69 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_69 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_70 Homo sapiens 9606 restricted access BioBankJapan T2D_70 male serum type 2 diabetes controlled access SAMD00552666 serum sample from blood of T2D subject T2D_70 serum from person with type 2 diabetes Sample collection T2D_70 Extraction T2D_70 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_70 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_71 Homo sapiens 9606 restricted access BioBankJapan T2D_71 male serum type 2 diabetes controlled access SAMD00552667 serum sample from blood of T2D subject T2D_71 serum from person with type 2 diabetes Sample collection T2D_71 Extraction T2D_71 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_71 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_72 Homo sapiens 9606 restricted access BioBankJapan T2D_72 male serum type 2 diabetes controlled access SAMD00552668 serum sample from blood of T2D subject T2D_72 serum from person with type 2 diabetes Sample collection T2D_72 Extraction T2D_72 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_72 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_73 Homo sapiens 9606 restricted access BioBankJapan T2D_73 male serum type 2 diabetes controlled access SAMD00552669 serum sample from blood of T2D subject T2D_73 serum from person with type 2 diabetes Sample collection T2D_73 Extraction T2D_73 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_73 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_74 Homo sapiens 9606 restricted access BioBankJapan T2D_74 female serum type 2 diabetes controlled access SAMD00552670 serum sample from blood of T2D subject T2D_74 serum from person with type 2 diabetes Sample collection T2D_74 Extraction T2D_74 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_74 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_75 Homo sapiens 9606 restricted access BioBankJapan T2D_75 male serum type 2 diabetes controlled access SAMD00552671 serum sample from blood of T2D subject T2D_75 serum from person with type 2 diabetes Sample collection T2D_75 Extraction T2D_75 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_75 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_76 Homo sapiens 9606 restricted access BioBankJapan T2D_76 male serum type 2 diabetes controlled access SAMD00552672 serum sample from blood of T2D subject T2D_76 serum from person with type 2 diabetes Sample collection T2D_76 Extraction T2D_76 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_76 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_77 Homo sapiens 9606 restricted access BioBankJapan T2D_77 male serum type 2 diabetes controlled access SAMD00552673 serum sample from blood of T2D subject T2D_77 serum from person with type 2 diabetes Sample collection T2D_77 Extraction T2D_77 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_77 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_78 Homo sapiens 9606 restricted access BioBankJapan T2D_78 female serum type 2 diabetes controlled access SAMD00552674 serum sample from blood of T2D subject T2D_78 serum from person with type 2 diabetes Sample collection T2D_78 Extraction T2D_78 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_78 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_79 Homo sapiens 9606 restricted access BioBankJapan T2D_79 male serum type 2 diabetes controlled access SAMD00552675 serum sample from blood of T2D subject T2D_79 serum from person with type 2 diabetes Sample collection T2D_79 Extraction T2D_79 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_79 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_80 Homo sapiens 9606 restricted access BioBankJapan T2D_80 male serum type 2 diabetes controlled access SAMD00552676 serum sample from blood of T2D subject T2D_80 serum from person with type 2 diabetes Sample collection T2D_80 Extraction T2D_80 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_80 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_81 Homo sapiens 9606 restricted access BioBankJapan T2D_81 female serum type 2 diabetes controlled access SAMD00552677 serum sample from blood of T2D subject T2D_81 serum from person with type 2 diabetes Sample collection T2D_81 Extraction T2D_81 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_81 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_82 Homo sapiens 9606 restricted access BioBankJapan T2D_82 female serum type 2 diabetes controlled access SAMD00552678 serum sample from blood of T2D subject T2D_82 serum from person with type 2 diabetes Sample collection T2D_82 Extraction T2D_82 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_82 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_83 Homo sapiens 9606 restricted access BioBankJapan T2D_83 female serum type 2 diabetes controlled access SAMD00552679 serum sample from blood of T2D subject T2D_83 serum from person with type 2 diabetes Sample collection T2D_83 Extraction T2D_83 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_83 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_84 Homo sapiens 9606 restricted access BioBankJapan T2D_84 female serum type 2 diabetes controlled access SAMD00552680 serum sample from blood of T2D subject T2D_84 serum from person with type 2 diabetes Sample collection T2D_84 Extraction T2D_84 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_84 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_85 Homo sapiens 9606 restricted access BioBankJapan T2D_85 male serum type 2 diabetes controlled access SAMD00552681 serum sample from blood of T2D subject T2D_85 serum from person with type 2 diabetes Sample collection T2D_85 Extraction T2D_85 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_85 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_86 Homo sapiens 9606 restricted access BioBankJapan T2D_86 male serum type 2 diabetes controlled access SAMD00552682 serum sample from blood of T2D subject T2D_86 serum from person with type 2 diabetes Sample collection T2D_86 Extraction T2D_86 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_86 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_87 Homo sapiens 9606 restricted access BioBankJapan T2D_87 female serum type 2 diabetes controlled access SAMD00552683 serum sample from blood of T2D subject T2D_87 serum from person with type 2 diabetes Sample collection T2D_87 Extraction T2D_87 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_87 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_88 Homo sapiens 9606 restricted access BioBankJapan T2D_88 male serum type 2 diabetes controlled access SAMD00552684 serum sample from blood of T2D subject T2D_88 serum from person with type 2 diabetes Sample collection T2D_88 Extraction T2D_88 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_88 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_89 Homo sapiens 9606 restricted access BioBankJapan T2D_89 male serum type 2 diabetes controlled access SAMD00552685 serum sample from blood of T2D subject T2D_89 serum from person with type 2 diabetes Sample collection T2D_89 Extraction T2D_89 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_89 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_90 Homo sapiens 9606 restricted access BioBankJapan T2D_90 female serum type 2 diabetes controlled access SAMD00552686 serum sample from blood of T2D subject T2D_90 serum from person with type 2 diabetes Sample collection T2D_90 Extraction T2D_90 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_90 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_91 Homo sapiens 9606 restricted access BioBankJapan T2D_91 male serum type 2 diabetes controlled access SAMD00552687 serum sample from blood of T2D subject T2D_91 serum from person with type 2 diabetes Sample collection T2D_91 Extraction T2D_91 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_91 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_92 Homo sapiens 9606 restricted access BioBankJapan T2D_92 female serum type 2 diabetes controlled access SAMD00552688 serum sample from blood of T2D subject T2D_92 serum from person with type 2 diabetes Sample collection T2D_92 Extraction T2D_92 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_92 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_93 Homo sapiens 9606 restricted access BioBankJapan T2D_93 male serum type 2 diabetes controlled access SAMD00552689 serum sample from blood of T2D subject T2D_93 serum from person with type 2 diabetes Sample collection T2D_93 Extraction T2D_93 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_93 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_94 Homo sapiens 9606 restricted access BioBankJapan T2D_94 male serum type 2 diabetes controlled access SAMD00552690 serum sample from blood of T2D subject T2D_94 serum from person with type 2 diabetes Sample collection T2D_94 Extraction T2D_94 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_94 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_95 Homo sapiens 9606 restricted access BioBankJapan T2D_95 male serum type 2 diabetes controlled access SAMD00552691 serum sample from blood of T2D subject T2D_95 serum from person with type 2 diabetes Sample collection T2D_95 Extraction T2D_95 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_95 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_96 Homo sapiens 9606 restricted access BioBankJapan T2D_96 female serum type 2 diabetes controlled access SAMD00552692 serum sample from blood of T2D subject T2D_96 serum from person with type 2 diabetes Sample collection T2D_96 Extraction T2D_96 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_96 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_97 Homo sapiens 9606 restricted access BioBankJapan T2D_97 male serum type 2 diabetes controlled access SAMD00552693 serum sample from blood of T2D subject T2D_97 serum from person with type 2 diabetes Sample collection T2D_97 Extraction T2D_97 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_97 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_98 Homo sapiens 9606 restricted access BioBankJapan T2D_98 male serum type 2 diabetes controlled access SAMD00552694 serum sample from blood of T2D subject T2D_98 serum from person with type 2 diabetes Sample collection T2D_98 Extraction T2D_98 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_98 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_99 Homo sapiens 9606 restricted access BioBankJapan T2D_99 female serum type 2 diabetes controlled access SAMD00552695 serum sample from blood of T2D subject T2D_99 serum from person with type 2 diabetes Sample collection T2D_99 Extraction T2D_99 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_99 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_100 Homo sapiens 9606 restricted access BioBankJapan T2D_100 female serum type 2 diabetes controlled access SAMD00552696 serum sample from blood of T2D subject T2D_100 serum from person with type 2 diabetes Sample collection T2D_100 Extraction T2D_100 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_100 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_101 Homo sapiens 9606 restricted access BioBankJapan T2D_101 male serum type 2 diabetes controlled access SAMD00552697 serum sample from blood of T2D subject T2D_101 serum from person with type 2 diabetes Sample collection T2D_101 Extraction T2D_101 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_101 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_102 Homo sapiens 9606 restricted access BioBankJapan T2D_102 female serum type 2 diabetes controlled access SAMD00552698 serum sample from blood of T2D subject T2D_102 serum from person with type 2 diabetes Sample collection T2D_102 Extraction T2D_102 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_102 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_103 Homo sapiens 9606 restricted access BioBankJapan T2D_103 female serum type 2 diabetes controlled access SAMD00552699 serum sample from blood of T2D subject T2D_103 serum from person with type 2 diabetes Sample collection T2D_103 Extraction T2D_103 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_103 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_104 Homo sapiens 9606 restricted access BioBankJapan T2D_104 female serum type 2 diabetes controlled access SAMD00552700 serum sample from blood of T2D subject T2D_104 serum from person with type 2 diabetes Sample collection T2D_104 Extraction T2D_104 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_104 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_105 Homo sapiens 9606 restricted access BioBankJapan T2D_105 male serum type 2 diabetes controlled access SAMD00552701 serum sample from blood of T2D subject T2D_105 serum from person with type 2 diabetes Sample collection T2D_105 Extraction T2D_105 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_105 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_106 Homo sapiens 9606 restricted access BioBankJapan T2D_106 female serum type 2 diabetes controlled access SAMD00552702 serum sample from blood of T2D subject T2D_106 serum from person with type 2 diabetes Sample collection T2D_106 Extraction T2D_106 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_106 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_107 Homo sapiens 9606 restricted access BioBankJapan T2D_107 female serum type 2 diabetes controlled access SAMD00552703 serum sample from blood of T2D subject T2D_107 serum from person with type 2 diabetes Sample collection T2D_107 Extraction T2D_107 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_107 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_108 Homo sapiens 9606 restricted access BioBankJapan T2D_108 female serum type 2 diabetes controlled access SAMD00552704 serum sample from blood of T2D subject T2D_108 serum from person with type 2 diabetes Sample collection T2D_108 Extraction T2D_108 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_108 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_109 Homo sapiens 9606 restricted access BioBankJapan T2D_109 male serum type 2 diabetes controlled access SAMD00552705 serum sample from blood of T2D subject T2D_109 serum from person with type 2 diabetes Sample collection T2D_109 Extraction T2D_109 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_109 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_110 Homo sapiens 9606 restricted access BioBankJapan T2D_110 female serum type 2 diabetes controlled access SAMD00552706 serum sample from blood of T2D subject T2D_110 serum from person with type 2 diabetes Sample collection T2D_110 Extraction T2D_110 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_110 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_111 Homo sapiens 9606 restricted access BioBankJapan T2D_111 female serum type 2 diabetes controlled access SAMD00552707 serum sample from blood of T2D subject T2D_111 serum from person with type 2 diabetes Sample collection T2D_111 Extraction T2D_111 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_111 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_112 Homo sapiens 9606 restricted access BioBankJapan T2D_112 female serum type 2 diabetes controlled access SAMD00552708 serum sample from blood of T2D subject T2D_112 serum from person with type 2 diabetes Sample collection T2D_112 Extraction T2D_112 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_112 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_113 Homo sapiens 9606 restricted access BioBankJapan T2D_113 male serum type 2 diabetes controlled access SAMD00552709 serum sample from blood of T2D subject T2D_113 serum from person with type 2 diabetes Sample collection T2D_113 Extraction T2D_113 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_113 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_114 Homo sapiens 9606 restricted access BioBankJapan T2D_114 male serum type 2 diabetes controlled access SAMD00552710 serum sample from blood of T2D subject T2D_114 serum from person with type 2 diabetes Sample collection T2D_114 Extraction T2D_114 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_114 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_115 Homo sapiens 9606 restricted access BioBankJapan T2D_115 male serum type 2 diabetes controlled access SAMD00552711 serum sample from blood of T2D subject T2D_115 serum from person with type 2 diabetes Sample collection T2D_115 Extraction T2D_115 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_115 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_116 Homo sapiens 9606 restricted access BioBankJapan T2D_116 female serum type 2 diabetes controlled access SAMD00552712 serum sample from blood of T2D subject T2D_116 serum from person with type 2 diabetes Sample collection T2D_116 Extraction T2D_116 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_116 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_117 Homo sapiens 9606 restricted access BioBankJapan T2D_117 female serum type 2 diabetes controlled access SAMD00552713 serum sample from blood of T2D subject T2D_117 serum from person with type 2 diabetes Sample collection T2D_117 Extraction T2D_117 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_117 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_118 Homo sapiens 9606 restricted access BioBankJapan T2D_118 male serum type 2 diabetes controlled access SAMD00552714 serum sample from blood of T2D subject T2D_118 serum from person with type 2 diabetes Sample collection T2D_118 Extraction T2D_118 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_118 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_119 Homo sapiens 9606 restricted access BioBankJapan T2D_119 female serum type 2 diabetes controlled access SAMD00552715 serum sample from blood of T2D subject T2D_119 serum from person with type 2 diabetes Sample collection T2D_119 Extraction T2D_119 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_119 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_120 Homo sapiens 9606 restricted access BioBankJapan T2D_120 female serum type 2 diabetes controlled access SAMD00552716 serum sample from blood of T2D subject T2D_120 serum from person with type 2 diabetes Sample collection T2D_120 Extraction T2D_120 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_120 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_121 Homo sapiens 9606 restricted access BioBankJapan T2D_121 male serum type 2 diabetes controlled access SAMD00552717 serum sample from blood of T2D subject T2D_121 serum from person with type 2 diabetes Sample collection T2D_121 Extraction T2D_121 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_121 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_122 Homo sapiens 9606 restricted access BioBankJapan T2D_122 male serum type 2 diabetes controlled access SAMD00552718 serum sample from blood of T2D subject T2D_122 serum from person with type 2 diabetes Sample collection T2D_122 Extraction T2D_122 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_122 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_123 Homo sapiens 9606 restricted access BioBankJapan T2D_123 male serum type 2 diabetes controlled access SAMD00552719 serum sample from blood of T2D subject T2D_123 serum from person with type 2 diabetes Sample collection T2D_123 Extraction T2D_123 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_123 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_124 Homo sapiens 9606 restricted access BioBankJapan T2D_124 female serum type 2 diabetes controlled access SAMD00552720 serum sample from blood of T2D subject T2D_124 serum from person with type 2 diabetes Sample collection T2D_124 Extraction T2D_124 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_124 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_125 Homo sapiens 9606 restricted access BioBankJapan T2D_125 male serum type 2 diabetes controlled access SAMD00552721 serum sample from blood of T2D subject T2D_125 serum from person with type 2 diabetes Sample collection T2D_125 Extraction T2D_125 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_125 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_126 Homo sapiens 9606 restricted access BioBankJapan T2D_126 male serum type 2 diabetes controlled access SAMD00552722 serum sample from blood of T2D subject T2D_126 serum from person with type 2 diabetes Sample collection T2D_126 Extraction T2D_126 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_126 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_127 Homo sapiens 9606 restricted access BioBankJapan T2D_127 female serum type 2 diabetes controlled access SAMD00552723 serum sample from blood of T2D subject T2D_127 serum from person with type 2 diabetes Sample collection T2D_127 Extraction T2D_127 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_127 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_128 Homo sapiens 9606 restricted access BioBankJapan T2D_128 female serum type 2 diabetes controlled access SAMD00552724 serum sample from blood of T2D subject T2D_128 serum from person with type 2 diabetes Sample collection T2D_128 Extraction T2D_128 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_128 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_129 Homo sapiens 9606 restricted access BioBankJapan T2D_129 female serum type 2 diabetes controlled access SAMD00552725 serum sample from blood of T2D subject T2D_129 serum from person with type 2 diabetes Sample collection T2D_129 Extraction T2D_129 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_129 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_130 Homo sapiens 9606 restricted access BioBankJapan T2D_130 male serum type 2 diabetes controlled access SAMD00552726 serum sample from blood of T2D subject T2D_130 serum from person with type 2 diabetes Sample collection T2D_130 Extraction T2D_130 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_130 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_131 Homo sapiens 9606 restricted access BioBankJapan T2D_131 male serum type 2 diabetes controlled access SAMD00552727 serum sample from blood of T2D subject T2D_131 serum from person with type 2 diabetes Sample collection T2D_131 Extraction T2D_131 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_131 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_132 Homo sapiens 9606 restricted access BioBankJapan T2D_132 female serum type 2 diabetes controlled access SAMD00552728 serum sample from blood of T2D subject T2D_132 serum from person with type 2 diabetes Sample collection T2D_132 Extraction T2D_132 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_132 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_133 Homo sapiens 9606 restricted access BioBankJapan T2D_133 female serum type 2 diabetes controlled access SAMD00552729 serum sample from blood of T2D subject T2D_133 serum from person with type 2 diabetes Sample collection T2D_133 Extraction T2D_133 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_133 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_134 Homo sapiens 9606 restricted access BioBankJapan T2D_134 male serum type 2 diabetes controlled access SAMD00552730 serum sample from blood of T2D subject T2D_134 serum from person with type 2 diabetes Sample collection T2D_134 Extraction T2D_134 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_134 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_135 Homo sapiens 9606 restricted access BioBankJapan T2D_135 male serum type 2 diabetes controlled access SAMD00552731 serum sample from blood of T2D subject T2D_135 serum from person with type 2 diabetes Sample collection T2D_135 Extraction T2D_135 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_135 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_136 Homo sapiens 9606 restricted access BioBankJapan T2D_136 female serum type 2 diabetes controlled access SAMD00552732 serum sample from blood of T2D subject T2D_136 serum from person with type 2 diabetes Sample collection T2D_136 Extraction T2D_136 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_136 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_137 Homo sapiens 9606 restricted access BioBankJapan T2D_137 female serum type 2 diabetes controlled access SAMD00552733 serum sample from blood of T2D subject T2D_137 serum from person with type 2 diabetes Sample collection T2D_137 Extraction T2D_137 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_137 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_138 Homo sapiens 9606 restricted access BioBankJapan T2D_138 male serum type 2 diabetes controlled access SAMD00552734 serum sample from blood of T2D subject T2D_138 serum from person with type 2 diabetes Sample collection T2D_138 Extraction T2D_138 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_138 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_139 Homo sapiens 9606 restricted access BioBankJapan T2D_139 female serum type 2 diabetes controlled access SAMD00552735 serum sample from blood of T2D subject T2D_139 serum from person with type 2 diabetes Sample collection T2D_139 Extraction T2D_139 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_139 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_140 Homo sapiens 9606 restricted access BioBankJapan T2D_140 male serum type 2 diabetes controlled access SAMD00552736 serum sample from blood of T2D subject T2D_140 serum from person with type 2 diabetes Sample collection T2D_140 Extraction T2D_140 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_140 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_141 Homo sapiens 9606 restricted access BioBankJapan T2D_141 male serum type 2 diabetes controlled access SAMD00552737 serum sample from blood of T2D subject T2D_141 serum from person with type 2 diabetes Sample collection T2D_141 Extraction T2D_141 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_141 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_142 Homo sapiens 9606 restricted access BioBankJapan T2D_142 male serum type 2 diabetes controlled access SAMD00552738 serum sample from blood of T2D subject T2D_142 serum from person with type 2 diabetes Sample collection T2D_142 Extraction T2D_142 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_142 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_143 Homo sapiens 9606 restricted access BioBankJapan T2D_143 female serum type 2 diabetes controlled access SAMD00552739 serum sample from blood of T2D subject T2D_143 serum from person with type 2 diabetes Sample collection T2D_143 Extraction T2D_143 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_143 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_144 Homo sapiens 9606 restricted access BioBankJapan T2D_144 female serum type 2 diabetes controlled access SAMD00552740 serum sample from blood of T2D subject T2D_144 serum from person with type 2 diabetes Sample collection T2D_144 Extraction T2D_144 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_144 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_145 Homo sapiens 9606 restricted access BioBankJapan T2D_145 male serum type 2 diabetes controlled access SAMD00552741 serum sample from blood of T2D subject T2D_145 serum from person with type 2 diabetes Sample collection T2D_145 Extraction T2D_145 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_145 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_146 Homo sapiens 9606 restricted access BioBankJapan T2D_146 male serum type 2 diabetes controlled access SAMD00552742 serum sample from blood of T2D subject T2D_146 serum from person with type 2 diabetes Sample collection T2D_146 Extraction T2D_146 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_146 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_147 Homo sapiens 9606 restricted access BioBankJapan T2D_147 female serum type 2 diabetes controlled access SAMD00552743 serum sample from blood of T2D subject T2D_147 serum from person with type 2 diabetes Sample collection T2D_147 Extraction T2D_147 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_147 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_148 Homo sapiens 9606 restricted access BioBankJapan T2D_148 male serum type 2 diabetes controlled access SAMD00552744 serum sample from blood of T2D subject T2D_148 serum from person with type 2 diabetes Sample collection T2D_148 Extraction T2D_148 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_148 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_149 Homo sapiens 9606 restricted access BioBankJapan T2D_149 female serum type 2 diabetes controlled access SAMD00552745 serum sample from blood of T2D subject T2D_149 serum from person with type 2 diabetes Sample collection T2D_149 Extraction T2D_149 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_149 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_150 Homo sapiens 9606 restricted access BioBankJapan T2D_150 male serum type 2 diabetes controlled access SAMD00552746 serum sample from blood of T2D subject T2D_150 serum from person with type 2 diabetes Sample collection T2D_150 Extraction T2D_150 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_150 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_151 Homo sapiens 9606 restricted access BioBankJapan T2D_151 female serum type 2 diabetes controlled access SAMD00552747 serum sample from blood of T2D subject T2D_151 serum from person with type 2 diabetes Sample collection T2D_151 Extraction T2D_151 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_151 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_152 Homo sapiens 9606 restricted access BioBankJapan T2D_152 male serum type 2 diabetes controlled access SAMD00552748 serum sample from blood of T2D subject T2D_152 serum from person with type 2 diabetes Sample collection T2D_152 Extraction T2D_152 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_152 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_153 Homo sapiens 9606 restricted access BioBankJapan T2D_153 female serum type 2 diabetes controlled access SAMD00552749 serum sample from blood of T2D subject T2D_153 serum from person with type 2 diabetes Sample collection T2D_153 Extraction T2D_153 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_153 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_154 Homo sapiens 9606 restricted access BioBankJapan T2D_154 male serum type 2 diabetes controlled access SAMD00552750 serum sample from blood of T2D subject T2D_154 serum from person with type 2 diabetes Sample collection T2D_154 Extraction T2D_154 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_154 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_155 Homo sapiens 9606 restricted access BioBankJapan T2D_155 female serum type 2 diabetes controlled access SAMD00552751 serum sample from blood of T2D subject T2D_155 serum from person with type 2 diabetes Sample collection T2D_155 Extraction T2D_155 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_155 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_156 Homo sapiens 9606 restricted access BioBankJapan T2D_156 male serum type 2 diabetes controlled access SAMD00552752 serum sample from blood of T2D subject T2D_156 serum from person with type 2 diabetes Sample collection T2D_156 Extraction T2D_156 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_156 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_157 Homo sapiens 9606 restricted access BioBankJapan T2D_157 male serum type 2 diabetes controlled access SAMD00552753 serum sample from blood of T2D subject T2D_157 serum from person with type 2 diabetes Sample collection T2D_157 Extraction T2D_157 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_157 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_158 Homo sapiens 9606 restricted access BioBankJapan T2D_158 female serum type 2 diabetes controlled access SAMD00552754 serum sample from blood of T2D subject T2D_158 serum from person with type 2 diabetes Sample collection T2D_158 Extraction T2D_158 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_158 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_159 Homo sapiens 9606 restricted access BioBankJapan T2D_159 male serum type 2 diabetes controlled access SAMD00552755 serum sample from blood of T2D subject T2D_159 serum from person with type 2 diabetes Sample collection T2D_159 Extraction T2D_159 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_159 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_160 Homo sapiens 9606 restricted access BioBankJapan T2D_160 female serum type 2 diabetes controlled access SAMD00552756 serum sample from blood of T2D subject T2D_160 serum from person with type 2 diabetes Sample collection T2D_160 Extraction T2D_160 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_160 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_161 Homo sapiens 9606 restricted access BioBankJapan T2D_161 male serum type 2 diabetes controlled access SAMD00552757 serum sample from blood of T2D subject T2D_161 serum from person with type 2 diabetes Sample collection T2D_161 Extraction T2D_161 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_161 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_162 Homo sapiens 9606 restricted access BioBankJapan T2D_162 male serum type 2 diabetes controlled access SAMD00552758 serum sample from blood of T2D subject T2D_162 serum from person with type 2 diabetes Sample collection T2D_162 Extraction T2D_162 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_162 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_163 Homo sapiens 9606 restricted access BioBankJapan T2D_163 male serum type 2 diabetes controlled access SAMD00552759 serum sample from blood of T2D subject T2D_163 serum from person with type 2 diabetes Sample collection T2D_163 Extraction T2D_163 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_163 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_164 Homo sapiens 9606 restricted access BioBankJapan T2D_164 male serum type 2 diabetes controlled access SAMD00552760 serum sample from blood of T2D subject T2D_164 serum from person with type 2 diabetes Sample collection T2D_164 Extraction T2D_164 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_164 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_165 Homo sapiens 9606 restricted access BioBankJapan T2D_165 female serum type 2 diabetes controlled access SAMD00552761 serum sample from blood of T2D subject T2D_165 serum from person with type 2 diabetes Sample collection T2D_165 Extraction T2D_165 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_165 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_166 Homo sapiens 9606 restricted access BioBankJapan T2D_166 male serum type 2 diabetes controlled access SAMD00552762 serum sample from blood of T2D subject T2D_166 serum from person with type 2 diabetes Sample collection T2D_166 Extraction T2D_166 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_166 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_167 Homo sapiens 9606 restricted access BioBankJapan T2D_167 male serum type 2 diabetes controlled access SAMD00552763 serum sample from blood of T2D subject T2D_167 serum from person with type 2 diabetes Sample collection T2D_167 Extraction T2D_167 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_167 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_168 Homo sapiens 9606 restricted access BioBankJapan T2D_168 male serum type 2 diabetes controlled access SAMD00552764 serum sample from blood of T2D subject T2D_168 serum from person with type 2 diabetes Sample collection T2D_168 Extraction T2D_168 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_168 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_169 Homo sapiens 9606 restricted access BioBankJapan T2D_169 male serum type 2 diabetes controlled access SAMD00552765 serum sample from blood of T2D subject T2D_169 serum from person with type 2 diabetes Sample collection T2D_169 Extraction T2D_169 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_169 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_170 Homo sapiens 9606 restricted access BioBankJapan T2D_170 male serum type 2 diabetes controlled access SAMD00552766 serum sample from blood of T2D subject T2D_170 serum from person with type 2 diabetes Sample collection T2D_170 Extraction T2D_170 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_170 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_171 Homo sapiens 9606 restricted access BioBankJapan T2D_171 female serum type 2 diabetes controlled access SAMD00552767 serum sample from blood of T2D subject T2D_171 serum from person with type 2 diabetes Sample collection T2D_171 Extraction T2D_171 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_171 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_172 Homo sapiens 9606 restricted access BioBankJapan T2D_172 male serum type 2 diabetes controlled access SAMD00552768 serum sample from blood of T2D subject T2D_172 serum from person with type 2 diabetes Sample collection T2D_172 Extraction T2D_172 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_172 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_173 Homo sapiens 9606 restricted access BioBankJapan T2D_173 female serum type 2 diabetes controlled access SAMD00552769 serum sample from blood of T2D subject T2D_173 serum from person with type 2 diabetes Sample collection T2D_173 Extraction T2D_173 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_173 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_174 Homo sapiens 9606 restricted access BioBankJapan T2D_174 female serum type 2 diabetes controlled access SAMD00552770 serum sample from blood of T2D subject T2D_174 serum from person with type 2 diabetes Sample collection T2D_174 Extraction T2D_174 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_174 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_175 Homo sapiens 9606 restricted access BioBankJapan T2D_175 female serum type 2 diabetes controlled access SAMD00552771 serum sample from blood of T2D subject T2D_175 serum from person with type 2 diabetes Sample collection T2D_175 Extraction T2D_175 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_175 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_176 Homo sapiens 9606 restricted access BioBankJapan T2D_176 male serum type 2 diabetes controlled access SAMD00552772 serum sample from blood of T2D subject T2D_176 serum from person with type 2 diabetes Sample collection T2D_176 Extraction T2D_176 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_176 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_177 Homo sapiens 9606 restricted access BioBankJapan T2D_177 male serum type 2 diabetes controlled access SAMD00552773 serum sample from blood of T2D subject T2D_177 serum from person with type 2 diabetes Sample collection T2D_177 Extraction T2D_177 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_177 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_178 Homo sapiens 9606 restricted access BioBankJapan T2D_178 male serum type 2 diabetes controlled access SAMD00552774 serum sample from blood of T2D subject T2D_178 serum from person with type 2 diabetes Sample collection T2D_178 Extraction T2D_178 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_178 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_179 Homo sapiens 9606 restricted access BioBankJapan T2D_179 male serum type 2 diabetes controlled access SAMD00552775 serum sample from blood of T2D subject T2D_179 serum from person with type 2 diabetes Sample collection T2D_179 Extraction T2D_179 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_179 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_180 Homo sapiens 9606 restricted access BioBankJapan T2D_180 male serum type 2 diabetes controlled access SAMD00552776 serum sample from blood of T2D subject T2D_180 serum from person with type 2 diabetes Sample collection T2D_180 Extraction T2D_180 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_180 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_181 Homo sapiens 9606 restricted access BioBankJapan T2D_181 female serum type 2 diabetes controlled access SAMD00552777 serum sample from blood of T2D subject T2D_181 serum from person with type 2 diabetes Sample collection T2D_181 Extraction T2D_181 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_181 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_182 Homo sapiens 9606 restricted access BioBankJapan T2D_182 female serum type 2 diabetes controlled access SAMD00552778 serum sample from blood of T2D subject T2D_182 serum from person with type 2 diabetes Sample collection T2D_182 Extraction T2D_182 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_182 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_183 Homo sapiens 9606 restricted access BioBankJapan T2D_183 male serum type 2 diabetes controlled access SAMD00552779 serum sample from blood of T2D subject T2D_183 serum from person with type 2 diabetes Sample collection T2D_183 Extraction T2D_183 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_183 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_184 Homo sapiens 9606 restricted access BioBankJapan T2D_184 male serum type 2 diabetes controlled access SAMD00552780 serum sample from blood of T2D subject T2D_184 serum from person with type 2 diabetes Sample collection T2D_184 Extraction T2D_184 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_184 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_185 Homo sapiens 9606 restricted access BioBankJapan T2D_185 female serum type 2 diabetes controlled access SAMD00552781 serum sample from blood of T2D subject T2D_185 serum from person with type 2 diabetes Sample collection T2D_185 Extraction T2D_185 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_185 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_186 Homo sapiens 9606 restricted access BioBankJapan T2D_186 female serum type 2 diabetes controlled access SAMD00552782 serum sample from blood of T2D subject T2D_186 serum from person with type 2 diabetes Sample collection T2D_186 Extraction T2D_186 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_186 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_187 Homo sapiens 9606 restricted access BioBankJapan T2D_187 female serum type 2 diabetes controlled access SAMD00552783 serum sample from blood of T2D subject T2D_187 serum from person with type 2 diabetes Sample collection T2D_187 Extraction T2D_187 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_187 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_188 Homo sapiens 9606 restricted access BioBankJapan T2D_188 male serum type 2 diabetes controlled access SAMD00552784 serum sample from blood of T2D subject T2D_188 serum from person with type 2 diabetes Sample collection T2D_188 Extraction T2D_188 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_188 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_189 Homo sapiens 9606 restricted access BioBankJapan T2D_189 female serum type 2 diabetes controlled access SAMD00552785 serum sample from blood of T2D subject T2D_189 serum from person with type 2 diabetes Sample collection T2D_189 Extraction T2D_189 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_189 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_190 Homo sapiens 9606 restricted access BioBankJapan T2D_190 female serum type 2 diabetes controlled access SAMD00552786 serum sample from blood of T2D subject T2D_190 serum from person with type 2 diabetes Sample collection T2D_190 Extraction T2D_190 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_190 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_191 Homo sapiens 9606 restricted access BioBankJapan T2D_191 male serum type 2 diabetes controlled access SAMD00552787 serum sample from blood of T2D subject T2D_191 serum from person with type 2 diabetes Sample collection T2D_191 Extraction T2D_191 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_191 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_192 Homo sapiens 9606 restricted access BioBankJapan T2D_192 male serum type 2 diabetes controlled access SAMD00552788 serum sample from blood of T2D subject T2D_192 serum from person with type 2 diabetes Sample collection T2D_192 Extraction T2D_192 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_192 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_193 Homo sapiens 9606 restricted access BioBankJapan T2D_193 female serum type 2 diabetes controlled access SAMD00552789 serum sample from blood of T2D subject T2D_193 serum from person with type 2 diabetes Sample collection T2D_193 Extraction T2D_193 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_193 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_194 Homo sapiens 9606 restricted access BioBankJapan T2D_194 male serum type 2 diabetes controlled access SAMD00552790 serum sample from blood of T2D subject T2D_194 serum from person with type 2 diabetes Sample collection T2D_194 Extraction T2D_194 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_194 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_195 Homo sapiens 9606 restricted access BioBankJapan T2D_195 male serum type 2 diabetes controlled access SAMD00552791 serum sample from blood of T2D subject T2D_195 serum from person with type 2 diabetes Sample collection T2D_195 Extraction T2D_195 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_195 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_196 Homo sapiens 9606 restricted access BioBankJapan T2D_196 female serum type 2 diabetes controlled access SAMD00552792 serum sample from blood of T2D subject T2D_196 serum from person with type 2 diabetes Sample collection T2D_196 Extraction T2D_196 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_196 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_197 Homo sapiens 9606 restricted access BioBankJapan T2D_197 female serum type 2 diabetes controlled access SAMD00552793 serum sample from blood of T2D subject T2D_197 serum from person with type 2 diabetes Sample collection T2D_197 Extraction T2D_197 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_197 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_198 Homo sapiens 9606 restricted access BioBankJapan T2D_198 female serum type 2 diabetes controlled access SAMD00552794 serum sample from blood of T2D subject T2D_198 serum from person with type 2 diabetes Sample collection T2D_198 Extraction T2D_198 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_198 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_199 Homo sapiens 9606 restricted access BioBankJapan T2D_199 male serum type 2 diabetes controlled access SAMD00552795 serum sample from blood of T2D subject T2D_199 serum from person with type 2 diabetes Sample collection T2D_199 Extraction T2D_199 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_199 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_200 Homo sapiens 9606 restricted access BioBankJapan T2D_200 male serum type 2 diabetes controlled access SAMD00552796 serum sample from blood of T2D subject T2D_200 serum from person with type 2 diabetes Sample collection T2D_200 Extraction T2D_200 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_200 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_201 Homo sapiens 9606 restricted access BioBankJapan T2D_201 male serum type 2 diabetes controlled access SAMD00552797 serum sample from blood of T2D subject T2D_201 serum from person with type 2 diabetes Sample collection T2D_201 Extraction T2D_201 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_201 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_202 Homo sapiens 9606 restricted access BioBankJapan T2D_202 female serum type 2 diabetes controlled access SAMD00552798 serum sample from blood of T2D subject T2D_202 serum from person with type 2 diabetes Sample collection T2D_202 Extraction T2D_202 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_202 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_203 Homo sapiens 9606 restricted access BioBankJapan T2D_203 male serum type 2 diabetes controlled access SAMD00552799 serum sample from blood of T2D subject T2D_203 serum from person with type 2 diabetes Sample collection T2D_203 Extraction T2D_203 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_203 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_204 Homo sapiens 9606 restricted access BioBankJapan T2D_204 male serum type 2 diabetes controlled access SAMD00552800 serum sample from blood of T2D subject T2D_204 serum from person with type 2 diabetes Sample collection T2D_204 Extraction T2D_204 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_204 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_205 Homo sapiens 9606 restricted access BioBankJapan T2D_205 female serum type 2 diabetes controlled access SAMD00552801 serum sample from blood of T2D subject T2D_205 serum from person with type 2 diabetes Sample collection T2D_205 Extraction T2D_205 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_205 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_206 Homo sapiens 9606 restricted access BioBankJapan T2D_206 male serum type 2 diabetes controlled access SAMD00552802 serum sample from blood of T2D subject T2D_206 serum from person with type 2 diabetes Sample collection T2D_206 Extraction T2D_206 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_206 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_207 Homo sapiens 9606 restricted access BioBankJapan T2D_207 male serum type 2 diabetes controlled access SAMD00552803 serum sample from blood of T2D subject T2D_207 serum from person with type 2 diabetes Sample collection T2D_207 Extraction T2D_207 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_207 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_208 Homo sapiens 9606 restricted access BioBankJapan T2D_208 female serum type 2 diabetes controlled access SAMD00552804 serum sample from blood of T2D subject T2D_208 serum from person with type 2 diabetes Sample collection T2D_208 Extraction T2D_208 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_208 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_209 Homo sapiens 9606 restricted access BioBankJapan T2D_209 female serum type 2 diabetes controlled access SAMD00552805 serum sample from blood of T2D subject T2D_209 serum from person with type 2 diabetes Sample collection T2D_209 Extraction T2D_209 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_209 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_210 Homo sapiens 9606 restricted access BioBankJapan T2D_210 male serum type 2 diabetes controlled access SAMD00552806 serum sample from blood of T2D subject T2D_210 serum from person with type 2 diabetes Sample collection T2D_210 Extraction T2D_210 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_210 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_211 Homo sapiens 9606 restricted access BioBankJapan T2D_211 female serum type 2 diabetes controlled access SAMD00552807 serum sample from blood of T2D subject T2D_211 serum from person with type 2 diabetes Sample collection T2D_211 Extraction T2D_211 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_211 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_212 Homo sapiens 9606 restricted access BioBankJapan T2D_212 male serum type 2 diabetes controlled access SAMD00552808 serum sample from blood of T2D subject T2D_212 serum from person with type 2 diabetes Sample collection T2D_212 Extraction T2D_212 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_212 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_213 Homo sapiens 9606 restricted access BioBankJapan T2D_213 male serum type 2 diabetes controlled access SAMD00552809 serum sample from blood of T2D subject T2D_213 serum from person with type 2 diabetes Sample collection T2D_213 Extraction T2D_213 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_213 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_214 Homo sapiens 9606 restricted access BioBankJapan T2D_214 female serum type 2 diabetes controlled access SAMD00552810 serum sample from blood of T2D subject T2D_214 serum from person with type 2 diabetes Sample collection T2D_214 Extraction T2D_214 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_214 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_215 Homo sapiens 9606 restricted access BioBankJapan T2D_215 female serum type 2 diabetes controlled access SAMD00552811 serum sample from blood of T2D subject T2D_215 serum from person with type 2 diabetes Sample collection T2D_215 Extraction T2D_215 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_215 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_216 Homo sapiens 9606 restricted access BioBankJapan T2D_216 male serum type 2 diabetes controlled access SAMD00552812 serum sample from blood of T2D subject T2D_216 serum from person with type 2 diabetes Sample collection T2D_216 Extraction T2D_216 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_216 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_217 Homo sapiens 9606 restricted access BioBankJapan T2D_217 female serum type 2 diabetes controlled access SAMD00552813 serum sample from blood of T2D subject T2D_217 serum from person with type 2 diabetes Sample collection T2D_217 Extraction T2D_217 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_217 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_218 Homo sapiens 9606 restricted access BioBankJapan T2D_218 male serum type 2 diabetes controlled access SAMD00552814 serum sample from blood of T2D subject T2D_218 serum from person with type 2 diabetes Sample collection T2D_218 Extraction T2D_218 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_218 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_219 Homo sapiens 9606 restricted access BioBankJapan T2D_219 female serum type 2 diabetes controlled access SAMD00552815 serum sample from blood of T2D subject T2D_219 serum from person with type 2 diabetes Sample collection T2D_219 Extraction T2D_219 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_219 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_220 Homo sapiens 9606 restricted access BioBankJapan T2D_220 female serum type 2 diabetes controlled access SAMD00552816 serum sample from blood of T2D subject T2D_220 serum from person with type 2 diabetes Sample collection T2D_220 Extraction T2D_220 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_220 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_221 Homo sapiens 9606 restricted access BioBankJapan T2D_221 male serum type 2 diabetes controlled access SAMD00552817 serum sample from blood of T2D subject T2D_221 serum from person with type 2 diabetes Sample collection T2D_221 Extraction T2D_221 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_221 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_222 Homo sapiens 9606 restricted access BioBankJapan T2D_222 male serum type 2 diabetes controlled access SAMD00552818 serum sample from blood of T2D subject T2D_222 serum from person with type 2 diabetes Sample collection T2D_222 Extraction T2D_222 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_222 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_223 Homo sapiens 9606 restricted access BioBankJapan T2D_223 male serum type 2 diabetes controlled access SAMD00552819 serum sample from blood of T2D subject T2D_223 serum from person with type 2 diabetes Sample collection T2D_223 Extraction T2D_223 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_223 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_224 Homo sapiens 9606 restricted access BioBankJapan T2D_224 female serum type 2 diabetes controlled access SAMD00552820 serum sample from blood of T2D subject T2D_224 serum from person with type 2 diabetes Sample collection T2D_224 Extraction T2D_224 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_224 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_225 Homo sapiens 9606 restricted access BioBankJapan T2D_225 male serum type 2 diabetes controlled access SAMD00552821 serum sample from blood of T2D subject T2D_225 serum from person with type 2 diabetes Sample collection T2D_225 Extraction T2D_225 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_225 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_226 Homo sapiens 9606 restricted access BioBankJapan T2D_226 male serum type 2 diabetes controlled access SAMD00552822 serum sample from blood of T2D subject T2D_226 serum from person with type 2 diabetes Sample collection T2D_226 Extraction T2D_226 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_226 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_227 Homo sapiens 9606 restricted access BioBankJapan T2D_227 male serum type 2 diabetes controlled access SAMD00552823 serum sample from blood of T2D subject T2D_227 serum from person with type 2 diabetes Sample collection T2D_227 Extraction T2D_227 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_227 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_228 Homo sapiens 9606 restricted access BioBankJapan T2D_228 male serum type 2 diabetes controlled access SAMD00552824 serum sample from blood of T2D subject T2D_228 serum from person with type 2 diabetes Sample collection T2D_228 Extraction T2D_228 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_228 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_229 Homo sapiens 9606 restricted access BioBankJapan T2D_229 male serum type 2 diabetes controlled access SAMD00552825 serum sample from blood of T2D subject T2D_229 serum from person with type 2 diabetes Sample collection T2D_229 Extraction T2D_229 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_229 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_230 Homo sapiens 9606 restricted access BioBankJapan T2D_230 male serum type 2 diabetes controlled access SAMD00552826 serum sample from blood of T2D subject T2D_230 serum from person with type 2 diabetes Sample collection T2D_230 Extraction T2D_230 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_230 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_231 Homo sapiens 9606 restricted access BioBankJapan T2D_231 male serum type 2 diabetes controlled access SAMD00552827 serum sample from blood of T2D subject T2D_231 serum from person with type 2 diabetes Sample collection T2D_231 Extraction T2D_231 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_231 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_232 Homo sapiens 9606 restricted access BioBankJapan T2D_232 male serum type 2 diabetes controlled access SAMD00552828 serum sample from blood of T2D subject T2D_232 serum from person with type 2 diabetes Sample collection T2D_232 Extraction T2D_232 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_232 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_233 Homo sapiens 9606 restricted access BioBankJapan T2D_233 female serum type 2 diabetes controlled access SAMD00552829 serum sample from blood of T2D subject T2D_233 serum from person with type 2 diabetes Sample collection T2D_233 Extraction T2D_233 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_233 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_234 Homo sapiens 9606 restricted access BioBankJapan T2D_234 male serum type 2 diabetes controlled access SAMD00552830 serum sample from blood of T2D subject T2D_234 serum from person with type 2 diabetes Sample collection T2D_234 Extraction T2D_234 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_234 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_235 Homo sapiens 9606 restricted access BioBankJapan T2D_235 female serum type 2 diabetes controlled access SAMD00552831 serum sample from blood of T2D subject T2D_235 serum from person with type 2 diabetes Sample collection T2D_235 Extraction T2D_235 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_235 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_236 Homo sapiens 9606 restricted access BioBankJapan T2D_236 male serum type 2 diabetes controlled access SAMD00552832 serum sample from blood of T2D subject T2D_236 serum from person with type 2 diabetes Sample collection T2D_236 Extraction T2D_236 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_236 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_237 Homo sapiens 9606 restricted access BioBankJapan T2D_237 male serum type 2 diabetes controlled access SAMD00552833 serum sample from blood of T2D subject T2D_237 serum from person with type 2 diabetes Sample collection T2D_237 Extraction T2D_237 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_237 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_238 Homo sapiens 9606 restricted access BioBankJapan T2D_238 male serum type 2 diabetes controlled access SAMD00552834 serum sample from blood of T2D subject T2D_238 serum from person with type 2 diabetes Sample collection T2D_238 Extraction T2D_238 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_238 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_239 Homo sapiens 9606 restricted access BioBankJapan T2D_239 female serum type 2 diabetes controlled access SAMD00552835 serum sample from blood of T2D subject T2D_239 serum from person with type 2 diabetes Sample collection T2D_239 Extraction T2D_239 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_239 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_240 Homo sapiens 9606 restricted access BioBankJapan T2D_240 male serum type 2 diabetes controlled access SAMD00552836 serum sample from blood of T2D subject T2D_240 serum from person with type 2 diabetes Sample collection T2D_240 Extraction T2D_240 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_240 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_241 Homo sapiens 9606 restricted access BioBankJapan T2D_241 female serum type 2 diabetes controlled access SAMD00552837 serum sample from blood of T2D subject T2D_241 serum from person with type 2 diabetes Sample collection T2D_241 Extraction T2D_241 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_241 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_242 Homo sapiens 9606 restricted access BioBankJapan T2D_242 male serum type 2 diabetes controlled access SAMD00552838 serum sample from blood of T2D subject T2D_242 serum from person with type 2 diabetes Sample collection T2D_242 Extraction T2D_242 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_242 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_243 Homo sapiens 9606 restricted access BioBankJapan T2D_243 male serum type 2 diabetes controlled access SAMD00552839 serum sample from blood of T2D subject T2D_243 serum from person with type 2 diabetes Sample collection T2D_243 Extraction T2D_243 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_243 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_244 Homo sapiens 9606 restricted access BioBankJapan T2D_244 female serum type 2 diabetes controlled access SAMD00552840 serum sample from blood of T2D subject T2D_244 serum from person with type 2 diabetes Sample collection T2D_244 Extraction T2D_244 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_244 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_245 Homo sapiens 9606 restricted access BioBankJapan T2D_245 female serum type 2 diabetes controlled access SAMD00552841 serum sample from blood of T2D subject T2D_245 serum from person with type 2 diabetes Sample collection T2D_245 Extraction T2D_245 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_245 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_246 Homo sapiens 9606 restricted access BioBankJapan T2D_246 male serum type 2 diabetes controlled access SAMD00552842 serum sample from blood of T2D subject T2D_246 serum from person with type 2 diabetes Sample collection T2D_246 Extraction T2D_246 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_246 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_247 Homo sapiens 9606 restricted access BioBankJapan T2D_247 male serum type 2 diabetes controlled access SAMD00552843 serum sample from blood of T2D subject T2D_247 serum from person with type 2 diabetes Sample collection T2D_247 Extraction T2D_247 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_247 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_248 Homo sapiens 9606 restricted access BioBankJapan T2D_248 female serum type 2 diabetes controlled access SAMD00552844 serum sample from blood of T2D subject T2D_248 serum from person with type 2 diabetes Sample collection T2D_248 Extraction T2D_248 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_248 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_249 Homo sapiens 9606 restricted access BioBankJapan T2D_249 male serum type 2 diabetes controlled access SAMD00552845 serum sample from blood of T2D subject T2D_249 serum from person with type 2 diabetes Sample collection T2D_249 Extraction T2D_249 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_249 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_250 Homo sapiens 9606 restricted access BioBankJapan T2D_250 male serum type 2 diabetes controlled access SAMD00552846 serum sample from blood of T2D subject T2D_250 serum from person with type 2 diabetes Sample collection T2D_250 Extraction T2D_250 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_250 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_251 Homo sapiens 9606 restricted access BioBankJapan T2D_251 female serum type 2 diabetes controlled access SAMD00552847 serum sample from blood of T2D subject T2D_251 serum from person with type 2 diabetes Sample collection T2D_251 Extraction T2D_251 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_251 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_252 Homo sapiens 9606 restricted access BioBankJapan T2D_252 male serum type 2 diabetes controlled access SAMD00552848 serum sample from blood of T2D subject T2D_252 serum from person with type 2 diabetes Sample collection T2D_252 Extraction T2D_252 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_252 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_253 Homo sapiens 9606 restricted access BioBankJapan T2D_253 male serum type 2 diabetes controlled access SAMD00552849 serum sample from blood of T2D subject T2D_253 serum from person with type 2 diabetes Sample collection T2D_253 Extraction T2D_253 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_253 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_254 Homo sapiens 9606 restricted access BioBankJapan T2D_254 female serum type 2 diabetes controlled access SAMD00552850 serum sample from blood of T2D subject T2D_254 serum from person with type 2 diabetes Sample collection T2D_254 Extraction T2D_254 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_254 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_255 Homo sapiens 9606 restricted access BioBankJapan T2D_255 male serum type 2 diabetes controlled access SAMD00552851 serum sample from blood of T2D subject T2D_255 serum from person with type 2 diabetes Sample collection T2D_255 Extraction T2D_255 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_255 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_256 Homo sapiens 9606 restricted access BioBankJapan T2D_256 male serum type 2 diabetes controlled access SAMD00552852 serum sample from blood of T2D subject T2D_256 serum from person with type 2 diabetes Sample collection T2D_256 Extraction T2D_256 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_256 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_257 Homo sapiens 9606 restricted access BioBankJapan T2D_257 female serum type 2 diabetes controlled access SAMD00552853 serum sample from blood of T2D subject T2D_257 serum from person with type 2 diabetes Sample collection T2D_257 Extraction T2D_257 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_257 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_258 Homo sapiens 9606 restricted access BioBankJapan T2D_258 male serum type 2 diabetes controlled access SAMD00552854 serum sample from blood of T2D subject T2D_258 serum from person with type 2 diabetes Sample collection T2D_258 Extraction T2D_258 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_258 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_259 Homo sapiens 9606 restricted access BioBankJapan T2D_259 female serum type 2 diabetes controlled access SAMD00552855 serum sample from blood of T2D subject T2D_259 serum from person with type 2 diabetes Sample collection T2D_259 Extraction T2D_259 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_259 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_260 Homo sapiens 9606 restricted access BioBankJapan T2D_260 male serum type 2 diabetes controlled access SAMD00552856 serum sample from blood of T2D subject T2D_260 serum from person with type 2 diabetes Sample collection T2D_260 Extraction T2D_260 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_260 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_261 Homo sapiens 9606 restricted access BioBankJapan T2D_261 female serum type 2 diabetes controlled access SAMD00552857 serum sample from blood of T2D subject T2D_261 serum from person with type 2 diabetes Sample collection T2D_261 Extraction T2D_261 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_261 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_262 Homo sapiens 9606 restricted access BioBankJapan T2D_262 male serum type 2 diabetes controlled access SAMD00552858 serum sample from blood of T2D subject T2D_262 serum from person with type 2 diabetes Sample collection T2D_262 Extraction T2D_262 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_262 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_263 Homo sapiens 9606 restricted access BioBankJapan T2D_263 male serum type 2 diabetes controlled access SAMD00552859 serum sample from blood of T2D subject T2D_263 serum from person with type 2 diabetes Sample collection T2D_263 Extraction T2D_263 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_263 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_264 Homo sapiens 9606 restricted access BioBankJapan T2D_264 male serum type 2 diabetes controlled access SAMD00552860 serum sample from blood of T2D subject T2D_264 serum from person with type 2 diabetes Sample collection T2D_264 Extraction T2D_264 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_264 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_265 Homo sapiens 9606 restricted access BioBankJapan T2D_265 male serum type 2 diabetes controlled access SAMD00552861 serum sample from blood of T2D subject T2D_265 serum from person with type 2 diabetes Sample collection T2D_265 Extraction T2D_265 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_265 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_266 Homo sapiens 9606 restricted access BioBankJapan T2D_266 male serum type 2 diabetes controlled access SAMD00552862 serum sample from blood of T2D subject T2D_266 serum from person with type 2 diabetes Sample collection T2D_266 Extraction T2D_266 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_266 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_267 Homo sapiens 9606 restricted access BioBankJapan T2D_267 male serum type 2 diabetes controlled access SAMD00552863 serum sample from blood of T2D subject T2D_267 serum from person with type 2 diabetes Sample collection T2D_267 Extraction T2D_267 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_267 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_268 Homo sapiens 9606 restricted access BioBankJapan T2D_268 female serum type 2 diabetes controlled access SAMD00552864 serum sample from blood of T2D subject T2D_268 serum from person with type 2 diabetes Sample collection T2D_268 Extraction T2D_268 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_268 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_269 Homo sapiens 9606 restricted access BioBankJapan T2D_269 female serum type 2 diabetes controlled access SAMD00552865 serum sample from blood of T2D subject T2D_269 serum from person with type 2 diabetes Sample collection T2D_269 Extraction T2D_269 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_269 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_270 Homo sapiens 9606 restricted access BioBankJapan T2D_270 male serum type 2 diabetes controlled access SAMD00552866 serum sample from blood of T2D subject T2D_270 serum from person with type 2 diabetes Sample collection T2D_270 Extraction T2D_270 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_270 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_271 Homo sapiens 9606 restricted access BioBankJapan T2D_271 male serum type 2 diabetes controlled access SAMD00552867 serum sample from blood of T2D subject T2D_271 serum from person with type 2 diabetes Sample collection T2D_271 Extraction T2D_271 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_271 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_272 Homo sapiens 9606 restricted access BioBankJapan T2D_272 female serum type 2 diabetes controlled access SAMD00552868 serum sample from blood of T2D subject T2D_272 serum from person with type 2 diabetes Sample collection T2D_272 Extraction T2D_272 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_272 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_273 Homo sapiens 9606 restricted access BioBankJapan T2D_273 male serum type 2 diabetes controlled access SAMD00552869 serum sample from blood of T2D subject T2D_273 serum from person with type 2 diabetes Sample collection T2D_273 Extraction T2D_273 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_273 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_274 Homo sapiens 9606 restricted access BioBankJapan T2D_274 female serum type 2 diabetes controlled access SAMD00552870 serum sample from blood of T2D subject T2D_274 serum from person with type 2 diabetes Sample collection T2D_274 Extraction T2D_274 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_274 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_275 Homo sapiens 9606 restricted access BioBankJapan T2D_275 female serum type 2 diabetes controlled access SAMD00552871 serum sample from blood of T2D subject T2D_275 serum from person with type 2 diabetes Sample collection T2D_275 Extraction T2D_275 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_275 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_276 Homo sapiens 9606 restricted access BioBankJapan T2D_276 male serum type 2 diabetes controlled access SAMD00552872 serum sample from blood of T2D subject T2D_276 serum from person with type 2 diabetes Sample collection T2D_276 Extraction T2D_276 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_276 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_277 Homo sapiens 9606 restricted access BioBankJapan T2D_277 male serum type 2 diabetes controlled access SAMD00552873 serum sample from blood of T2D subject T2D_277 serum from person with type 2 diabetes Sample collection T2D_277 Extraction T2D_277 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_277 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_278 Homo sapiens 9606 restricted access BioBankJapan T2D_278 female serum type 2 diabetes controlled access SAMD00552874 serum sample from blood of T2D subject T2D_278 serum from person with type 2 diabetes Sample collection T2D_278 Extraction T2D_278 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_278 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_279 Homo sapiens 9606 restricted access BioBankJapan T2D_279 female serum type 2 diabetes controlled access SAMD00552875 serum sample from blood of T2D subject T2D_279 serum from person with type 2 diabetes Sample collection T2D_279 Extraction T2D_279 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_279 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_280 Homo sapiens 9606 restricted access BioBankJapan T2D_280 female serum type 2 diabetes controlled access SAMD00552876 serum sample from blood of T2D subject T2D_280 serum from person with type 2 diabetes Sample collection T2D_280 Extraction T2D_280 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_280 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_281 Homo sapiens 9606 restricted access BioBankJapan T2D_281 female serum type 2 diabetes controlled access SAMD00552877 serum sample from blood of T2D subject T2D_281 serum from person with type 2 diabetes Sample collection T2D_281 Extraction T2D_281 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_281 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_282 Homo sapiens 9606 restricted access BioBankJapan T2D_282 male serum type 2 diabetes controlled access SAMD00552878 serum sample from blood of T2D subject T2D_282 serum from person with type 2 diabetes Sample collection T2D_282 Extraction T2D_282 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_282 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_283 Homo sapiens 9606 restricted access BioBankJapan T2D_283 male serum type 2 diabetes controlled access SAMD00552879 serum sample from blood of T2D subject T2D_283 serum from person with type 2 diabetes Sample collection T2D_283 Extraction T2D_283 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_283 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_284 Homo sapiens 9606 restricted access BioBankJapan T2D_284 male serum type 2 diabetes controlled access SAMD00552880 serum sample from blood of T2D subject T2D_284 serum from person with type 2 diabetes Sample collection T2D_284 Extraction T2D_284 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_284 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_285 Homo sapiens 9606 restricted access BioBankJapan T2D_285 female serum type 2 diabetes controlled access SAMD00552881 serum sample from blood of T2D subject T2D_285 serum from person with type 2 diabetes Sample collection T2D_285 Extraction T2D_285 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_285 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_286 Homo sapiens 9606 restricted access BioBankJapan T2D_286 male serum type 2 diabetes controlled access SAMD00552882 serum sample from blood of T2D subject T2D_286 serum from person with type 2 diabetes Sample collection T2D_286 Extraction T2D_286 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_286 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_287 Homo sapiens 9606 restricted access BioBankJapan T2D_287 male serum type 2 diabetes controlled access SAMD00552883 serum sample from blood of T2D subject T2D_287 serum from person with type 2 diabetes Sample collection T2D_287 Extraction T2D_287 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_287 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_288 Homo sapiens 9606 restricted access BioBankJapan T2D_288 female serum type 2 diabetes controlled access SAMD00552884 serum sample from blood of T2D subject T2D_288 serum from person with type 2 diabetes Sample collection T2D_288 Extraction T2D_288 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_288 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_289 Homo sapiens 9606 restricted access BioBankJapan T2D_289 male serum type 2 diabetes controlled access SAMD00552885 serum sample from blood of T2D subject T2D_289 serum from person with type 2 diabetes Sample collection T2D_289 Extraction T2D_289 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_289 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_290 Homo sapiens 9606 restricted access BioBankJapan T2D_290 female serum type 2 diabetes controlled access SAMD00552886 serum sample from blood of T2D subject T2D_290 serum from person with type 2 diabetes Sample collection T2D_290 Extraction T2D_290 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_290 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_291 Homo sapiens 9606 restricted access BioBankJapan T2D_291 female serum type 2 diabetes controlled access SAMD00552887 serum sample from blood of T2D subject T2D_291 serum from person with type 2 diabetes Sample collection T2D_291 Extraction T2D_291 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_291 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_292 Homo sapiens 9606 restricted access BioBankJapan T2D_292 female serum type 2 diabetes controlled access SAMD00552888 serum sample from blood of T2D subject T2D_292 serum from person with type 2 diabetes Sample collection T2D_292 Extraction T2D_292 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_292 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_293 Homo sapiens 9606 restricted access BioBankJapan T2D_293 male serum type 2 diabetes controlled access SAMD00552889 serum sample from blood of T2D subject T2D_293 serum from person with type 2 diabetes Sample collection T2D_293 Extraction T2D_293 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_293 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_294 Homo sapiens 9606 restricted access BioBankJapan T2D_294 male serum type 2 diabetes controlled access SAMD00552890 serum sample from blood of T2D subject T2D_294 serum from person with type 2 diabetes Sample collection T2D_294 Extraction T2D_294 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_294 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_295 Homo sapiens 9606 restricted access BioBankJapan T2D_295 female serum type 2 diabetes controlled access SAMD00552891 serum sample from blood of T2D subject T2D_295 serum from person with type 2 diabetes Sample collection T2D_295 Extraction T2D_295 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_295 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_296 Homo sapiens 9606 restricted access BioBankJapan T2D_296 female serum type 2 diabetes controlled access SAMD00552892 serum sample from blood of T2D subject T2D_296 serum from person with type 2 diabetes Sample collection T2D_296 Extraction T2D_296 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_296 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_297 Homo sapiens 9606 restricted access BioBankJapan T2D_297 male serum type 2 diabetes controlled access SAMD00552893 serum sample from blood of T2D subject T2D_297 serum from person with type 2 diabetes Sample collection T2D_297 Extraction T2D_297 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_297 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_298 Homo sapiens 9606 restricted access BioBankJapan T2D_298 female serum type 2 diabetes controlled access SAMD00552894 serum sample from blood of T2D subject T2D_298 serum from person with type 2 diabetes Sample collection T2D_298 Extraction T2D_298 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_298 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_299 Homo sapiens 9606 restricted access BioBankJapan T2D_299 male serum type 2 diabetes controlled access SAMD00552895 serum sample from blood of T2D subject T2D_299 serum from person with type 2 diabetes Sample collection T2D_299 Extraction T2D_299 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_299 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access T2D_300 Homo sapiens 9606 restricted access BioBankJapan T2D_300 female serum type 2 diabetes controlled access SAMD00552896 serum sample from blood of T2D subject T2D_300 serum from person with type 2 diabetes Sample collection T2D_300 Extraction T2D_300 Chromatography Agilent 1200 series RRLC system SL (Agilent Technologies) ODS column (2 x 50 mm, 2 micrometer) reverse phase Mass spectrometry positive and negative 50-1000 Agilent 6230 TOF MS (Agilent Technologies) time-of-flight T2D_300 Data processing processed/Sumstats_for_assoc_analysis_LC.tsv processed/Sumstats_for_assoc_analysis.tsv Metabolite identification controlled access